Methotrexate is a potent DHFR inhibitor. It affects NF-κB signaling pathways, by targeting DHFR, thereby inhibiting tumor growth.
Methotrexate IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Methotrexate Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Methotrexate Mechanism of Action: Dihydrofolate Reductase Inhibition in Lymphocyte Research
- Methotrexate Clinical Trials
- Methotrexate Working Concentration | Cell Culture | Treatment
- Methotrexate Solubility in DMSO
- Methotrexate Storage
- Methotrexate Stability
- Methotrexate Combination Database
- Methotrexate Molecular Weight
- Methotrexate SMILES
- Methotrexate CAS Number
- Methotrexate Chemical Structure (2D and 3D)
- Methotrexate Cayman (13960)? Try a better option.
- Methotrexate MedChemExpress (HY-14519)? Try a better option.
- Methotrexate Sigma (PHR1396)? Try a better option.
- Methotrexate APExBIO (A4347)? Try a better option.
- Methotrexate SDS｜MSDS